FindTrial
Sign In

Establishment and application of intelligent screening-diagnosis-assessment technology for newborns or children with congenital heart disease based on medical association

Establishment and application of intelligent screening-diagnosis-assessment technology for newborns or children with congenital heart disease based on medical association

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000035170
Enrollment
Unknown
Registered
2020-08-02
Start date
2020-09-01
Completion date
Unknown
Last updated
2020-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Heart Disease

Interventions

Gold Standard:remote auscultation
Index test:intelligent&#32
diagnosis

Sponsors

Shanghai Children's Medical Center,Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: Newborns or children under 18 years

Exclusion criteria

Exclusion criteria: 1. Fetal ultrasound confirmed those children with congenital heart disease; 2. Children with severe pneumonia.

Design outcomes

Primary

MeasureTime frame
oxygen saturation;heart sound auscultation;Face photos or videos;—

Countries

China

Contacts

Public ContactHuiwen Chen

Shanghai Children's Medical Center affiliated to medical school of Shanghai Jiaotong University

chenhuiwen@scmc.com.cn+86 18930830797

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026